|
| Clinical research progress of Chinese medicine treatment of cervical high-risk human papilloma virus infection |
| Hits 1733 Download times 1204 Received:April 20, 2018 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1673-9043.2018.05.21 |
| Key Words
Uterus;HPV;Chinese traditional treatment;Clinical research progress |
| Author Name | Affiliation | E-mail | | WEN Lijuan | First Clinical Medical school of Beijing University of Chinese Medicine, Beijing 100700, China | | | ZHANG Yun | First Clinical Medical school of Beijing University of Chinese Medicine, Beijing 100700, China | | | XUE Xiaoou | First Clinical Medical School of Beijing University of Chinese Medicine, Beijing 100700, China | pro_xue@163.com |
|
| Abstract
|
| High risk human papillomavirus (HR-HPV) infection is a primary factor in cervical carcinogenesis, HR-HPV is the leading cause of cervical precancerous lesions (CIN) and cervical cancer (CC) is the main cause. There is no anti HR-HPV infection drug effect is available. In this paper, for the past ten years, the Chinese medicine treatment of cervical high-risk people HPV infection in the literature to summarize, found that Chinese medicine treatment of cervical high-risk human papilloma virus infection method to find good curative effect, it is an effective treatment for cervical HR-HPV infection, persistent infection blocking state, change the reversal of CIN pathology, is of great significance to occur in the prevention of cervical cancer. |
|
|
|
|
|
